Kaplan MM - Search Results

1

Reduced tissue thyroid hormone levels in fatal illness.

Arem R, Wiener GJ, Kaplan SG, Kim HS, Reichlin S, Kaplan MM. Arem R, et al. Among authors: kaplan mm, kaplan sg. Metabolism. 1993 Sep;42(9):1102-8. doi: 10.1016/0026-0495(93)90266-q. Metabolism. 1993. PMID: 8412761

2

The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience.

Gagel RF, Tashjian AH Jr, Cummings T, Papathanasopoulos N, Kaplan MM, DeLellis RA, Wolfe HJ, Reichlin S. Gagel RF, et al. Among authors: kaplan mm. N Engl J Med. 1988 Feb 25;318(8):478-84. doi: 10.1056/NEJM198802253180804. N Engl J Med. 1988. PMID: 2893259

3

High-sensitivity serum calcitonin assays applied to screening for thyroid C-cell disease in multiple endocrine neoplasia type 2A.

Kaplan MM, Stall GM, Cummings T, MacAulay A, Motté P, Wolfe HJ, Reichlin S, Tashjian AH Jr. Kaplan MM, et al. Henry Ford Hosp Med J. 1992;40(3-4):227-31. Henry Ford Hosp Med J. 1992. PMID: 1362411 Free article.

4

Inhibition of thyroxine 5'-deiodination type II in cultured human placental cells by cortisol, insulin, 3', 5'-cyclic adenosine monophosphate, and butyrate.

Hidal JT, Kaplan MM. Hidal JT, et al. Among authors: kaplan mm. Metabolism. 1988 Jul;37(7):664-8. doi: 10.1016/0026-0495(88)90087-x. Metabolism. 1988. PMID: 2838733

5

Phenolic and tyrosyl ring iodothyronine deiodination by the Caco-2 human colon carcinoma cell line.

Lee JK, Gordon PR, Stall GM, Gilchrest BA, Kaplan MM. Lee JK, et al. Among authors: kaplan mm. Metabolism. 1989 Dec;38(12):1154-61. doi: 10.1016/0026-0495(89)90151-0. Metabolism. 1989. PMID: 2593828

6

Human epidermal keratinocytes in culture convert thyroxine to 3,5,3'-triiodothyronine by type II iodothyronine deiodination: a novel endocrine function of the skin.

Kaplan MM, Pan CY, Gordon PR, Lee JK, Gilchrest BA. Kaplan MM, et al. J Clin Endocrinol Metab. 1988 Apr;66(4):815-22. doi: 10.1210/jcem-66-4-815. J Clin Endocrinol Metab. 1988. PMID: 2450104

7

Antipyrine kinetics in patients with primary biliary cirrhosis.

von Moltke LL, Abernethy DR, Kaplan MM, Greenblatt DJ. von Moltke LL, et al. Among authors: kaplan mm. J Clin Pharmacol. 1993 Jan;33(1):75-7. doi: 10.1002/j.1552-4604.1993.tb03907.x. J Clin Pharmacol. 1993. PMID: 8429118

8

Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells.

Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Atkins MB, et al. Among authors: kaplan mm. N Engl J Med. 1988 Jun 16;318(24):1557-63. doi: 10.1056/NEJM198806163182401. N Engl J Med. 1988. PMID: 3259674

9

Keratinocytes convert thyroxine to triiodothyronine.

Kaplan MM, Gordon PR, Pan CY, Lee JK, Gilchrest BA. Kaplan MM, et al. Ann N Y Acad Sci. 1988;548:56-65. doi: 10.1111/j.1749-6632.1988.tb18792.x. Ann N Y Acad Sci. 1988. PMID: 2470307 No abstract available.

10

Potential neuroprotective effects of 2-hydroxypropyl-β cyclodextrin against amyloid β (1-42)-induced neurotoxicity on the rat hippocampus.

Yalcin A, Turunc E, Kaplan MM, Uyanikgil Y, Erzurumlu Y, Gavini E, Kanit L. Yalcin A, et al. Among authors: kaplan mm. Drug Chem Toxicol. 2024 May 10:1-8. doi: 10.1080/01480545.2024.2349951. Online ahead of print. Drug Chem Toxicol. 2024. PMID: 38726980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

393 results

Search Page